MedPlus Health Services (MEDPLUS) Stock Overview
Engages in the retail trading of medicines and general items in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for MEDPLUS from our risk checks.
MEDPLUS Community Fair Values
Create NarrativeSee what 9 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
MedPlus Health Services Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹868.90 |
| 52 Week High | ₹1,022.20 |
| 52 Week Low | ₹732.00 |
| Beta | 0.43 |
| 1 Month Change | -8.63% |
| 3 Month Change | 2.78% |
| 1 Year Change | 0.029% |
| 3 Year Change | 7.15% |
| 5 Year Change | n/a |
| Change since IPO | -22.50% |
Recent News & Updates
Narrative Update • Jun 04
MEDPLUS: CSR Subsidiary And AGM Timeline Will Support Bullish Repricing
Analysts have raised the price target on MedPlus Health Services from ₹1,059.71 to ₹1,168.71, citing updated assumptions around revenue growth, profit margins, discount rate, and expected future P/E. What's in the News A board meeting is scheduled for May 20, 2026, at 14:00 IST to consider and approve audited standalone and consolidated financial results for the quarter and full year ended March 31, 2026.Analysis Article • May 28
MedPlus Health Services' (NSE:MEDPLUS) Strong Earnings Are Of Good Quality
The subdued stock price reaction suggests that MedPlus Health Services Limited's ( NSE:MEDPLUS ) strong earnings didn't...Analysis Article • May 23
MedPlus Health Services Limited (NSE:MEDPLUS) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?
MedPlus Health Services Limited ( NSE:MEDPLUS ) shareholders are probably feeling a little disappointed, since its...Recent updates
Narrative Update • Jun 04
MEDPLUS: CSR Subsidiary And AGM Timeline Will Support Bullish Repricing
Analysts have raised the price target on MedPlus Health Services from ₹1,059.71 to ₹1,168.71, citing updated assumptions around revenue growth, profit margins, discount rate, and expected future P/E. What's in the News A board meeting is scheduled for May 20, 2026, at 14:00 IST to consider and approve audited standalone and consolidated financial results for the quarter and full year ended March 31, 2026.Analysis Article • May 28
MedPlus Health Services' (NSE:MEDPLUS) Strong Earnings Are Of Good Quality
The subdued stock price reaction suggests that MedPlus Health Services Limited's ( NSE:MEDPLUS ) strong earnings didn't...Analysis Article • May 23
MedPlus Health Services Limited (NSE:MEDPLUS) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?
MedPlus Health Services Limited ( NSE:MEDPLUS ) shareholders are probably feeling a little disappointed, since its...Analysis Article • May 20
With EPS Growth And More, MedPlus Health Services (NSE:MEDPLUS) Makes An Interesting Case
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...Analysis Article • Feb 04
MedPlus Health Services Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year
It's been a pretty great week for MedPlus Health Services Limited ( NSE:MEDPLUS ) shareholders, with its shares surging...Analysis Article • Nov 29
Is MedPlus Health Services Limited (NSE:MEDPLUS) Expensive For A Reason? A Look At Its Intrinsic Value
Key Insights MedPlus Health Services' estimated fair value is ₹640 based on 2 Stage Free Cash Flow to Equity MedPlus...Analysis Article • Nov 05
MedPlus Health Services Limited Just Beat EPS By 13%: Here's What Analysts Think Will Happen Next
It's been a good week for MedPlus Health Services Limited ( NSE:MEDPLUS ) shareholders, because the company has just...Analysis Article • Sep 25
MedPlus Health Services' (NSE:MEDPLUS) Returns On Capital Not Reflecting Well On The Business
If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...Narrative Update • Sep 05
Diagnostics Expansion And Private Labels Will Strengthen Market Position
MedPlus Health Services’ fair value has seen a marginal downward revision to ₹1,060 as analysts respond to a sharp rise in future P/E and a notable decline in net profit margin. What's in the News Board meeting scheduled for Aug 02 to review and approve unaudited standalone and consolidated financial results for the quarter ended June 30, 2025, and to consider other matters.Analysis Article • Aug 06
Earnings Beat: MedPlus Health Services Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
NSEI:MEDPLUS 1 Year Share Price vs Fair Value Explore MedPlus Health Services's Fair Values from the Community and...Analysis Article • Jul 16
Market Participants Recognise MedPlus Health Services Limited's (NSE:MEDPLUS) Earnings
MedPlus Health Services Limited's ( NSE:MEDPLUS ) price-to-earnings (or "P/E") ratio of 72.6x might make it look like a...Analysis Article • May 31
₹1,053 - That's What Analysts Think MedPlus Health Services Limited (NSE:MEDPLUS) Is Worth After These Results
As you might know, MedPlus Health Services Limited ( NSE:MEDPLUS ) recently reported its yearly numbers. MedPlus Health...Analysis Article • May 18
Here's What's Concerning About MedPlus Health Services' (NSE:MEDPLUS) Returns On Capital
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...Analysis Article • Mar 26
MedPlus Health Services Limited's (NSE:MEDPLUS) P/E Still Appears To Be Reasonable
MedPlus Health Services Limited's ( NSE:MEDPLUS ) price-to-earnings (or "P/E") ratio of 68.3x might make it look like a...
New Narrative • Feb 06
Opening 600 New Stores And Improving Operations Will Expand Future Market Reach
Expansion with new warehouses and 600 stores will enhance supply chain, boost revenue, and drive significant top-line growth.Analysis Article • Feb 05
MedPlus Health Services Limited (NSE:MEDPLUS) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
Investors in MedPlus Health Services Limited ( NSE:MEDPLUS ) had a good week, as its shares rose 8.3% to close at ₹769...Analysis Article • Jan 28
A Look At The Fair Value Of MedPlus Health Services Limited (NSE:MEDPLUS)
Key Insights MedPlus Health Services' estimated fair value is ₹772 based on 2 Stage Free Cash Flow to Equity With ₹714...Analysis Article • Dec 05
Even With A 27% Surge, Cautious Investors Are Not Rewarding MedPlus Health Services Limited's (NSE:MEDPLUS) Performance Completely
MedPlus Health Services Limited ( NSE:MEDPLUS ) shares have had a really impressive month, gaining 27% after a shaky...Analysis Article • Aug 30
There Are Reasons To Feel Uneasy About MedPlus Health Services' (NSE:MEDPLUS) Returns On Capital
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...Analysis Article • Feb 03
Is Now The Time To Put MedPlus Health Services (NSE:MEDPLUS) On Your Watchlist?
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...Analysis Article • Dec 11
MedPlus Health Services (NSE:MEDPLUS) Will Want To Turn Around Its Return Trends
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...Analysis Article • Oct 24
A Look At The Intrinsic Value Of MedPlus Health Services Limited (NSE:MEDPLUS)
Key Insights The projected fair value for MedPlus Health Services is ₹727 based on 2 Stage Free Cash Flow to Equity...Analysis Article • Jul 18
The Returns On Capital At MedPlus Health Services (NSE:MEDPLUS) Don't Inspire Confidence
If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...Analysis Article • Jun 22
Why Investors Shouldn't Be Surprised By MedPlus Health Services Limited's (NSE:MEDPLUS) P/S
When you see that almost half of the companies in the Consumer Retailing industry in India have price-to-sales ratios...Analysis Article • Apr 18
A Look At The Fair Value Of MedPlus Health Services Limited (NSE:MEDPLUS)
Key Insights Using the 2 Stage Free Cash Flow to Equity, MedPlus Health Services fair value estimate is ₹674 Current...Analysis Article • Feb 08
MedPlus Health Services (NSE:MEDPLUS) Could Be Struggling To Allocate Capital
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...Analysis Article • Jun 03
₹1,177: That's What Analysts Think MedPlus Health Services Limited (NSE:MEDPLUS) Is Worth After Its Latest Results
MedPlus Health Services Limited ( NSE:MEDPLUS ) shareholders are probably feeling a little disappointed, since its...Shareholder Returns
| MEDPLUS | IN Consumer Retailing | IN Market | |
|---|---|---|---|
| 7D | 0.9% | 1.1% | 2.8% |
| 1Y | 0.03% | -0.7% | -1.5% |
Return vs Industry: MEDPLUS matched the Indian Consumer Retailing industry which returned -0.7% over the past year.
Return vs Market: MEDPLUS exceeded the Indian Market which returned -1.5% over the past year.
Price Volatility
| MEDPLUS volatility | |
|---|---|
| MEDPLUS Average Weekly Movement | 4.5% |
| Consumer Retailing Industry Average Movement | 8.0% |
| Market Average Movement | 7.1% |
| 10% most volatile stocks in IN Market | 10.2% |
| 10% least volatile stocks in IN Market | 4.7% |
Stable Share Price: MEDPLUS has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: MEDPLUS's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 25,007 | Gangadi Reddy | www.medplusindia.com |
MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, such as prescription medicines, over-the-counter drugs, vitamins, medical devices, and diagnostic test kits; and fast-moving consumer goods (FMCG), including personal and home care products like toiletries, baby care items, soaps, detergents, and sanitizers. The company also engages in wholesale cash and carry; provision of diagnostic, pathological, and laboratory testing services, as well as contract manufacturing of private-label pharmaceuticals, wellness products, and FMCG goods; and operates diagnostic centres.
MedPlus Health Services Limited Fundamentals Summary
| MEDPLUS fundamental statistics | |
|---|---|
| Market cap | ₹104.32b |
| Earnings (TTM) | ₹2.20b |
| Revenue (TTM) | ₹68.92b |
47.5x
P/E Ratio1.5x
P/S RatioIs MEDPLUS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MEDPLUS income statement (TTM) | |
|---|---|
| Revenue | ₹68.92b |
| Cost of Revenue | ₹50.85b |
| Gross Profit | ₹18.08b |
| Other Expenses | ₹15.88b |
| Earnings | ₹2.20b |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 18.30 |
| Gross Margin | 26.23% |
| Net Profit Margin | 3.19% |
| Debt/Equity Ratio | 0% |
How did MEDPLUS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/16 16:29 |
| End of Day Share Price | 2026/06/16 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2026/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
MedPlus Health Services Limited is covered by 12 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Akhil Parekh | 360 ONE Capital Market Private Limited |
| Harith Ahamed | Avendus Spark |
| Sudarshan Agarwal | Axis Capital Limited |